← Open Payments lookup

ANNAMARIA GRAFFEO: Open Payments

NPI 1336867068 · DANVERS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,522 in 146 payments from 12 companies in 2025. Trend: 2023 $1,897 · 2024 $2,201 · 2025 $3,522

Food & beverage: $3,498Education: $23
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.24$770
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$516
Alkermes, Inc.20$485
Otsuka America Pharmaceutical, Inc.16$342
Vanda Pharmaceuticals Inc.18$320
Janssen Pharmaceuticals, Inc12$305
E.R. Squibb & Sons, L.L.C.15$299
Lundbeck LLC11$252
ABBVIE INC.7$140
Takeda Pharmaceuticals U.S.A., Inc.2$36

Products named: INGREZZA, REXULTI, CAPLYTA, FANAPT, ARISTADA, COBENFY, INVEGA SUSTENNA, LYBALVI.

Industry payments across MA — which companies pay providers there.